Shenzhen Hepalink Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 72% in First Quarter of 2023

Shenzhen Hepalink Pharmaceutical Group Co.,Ltd. (深圳市海普瑞药业集团股份有限公司) (002399.SZ) reported a net profit of 65.9 million yuan in the first quarter of 2023, down 72% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, down 31.9% year-on-year.

At the end of the reporting period, it had 20.6 billion yuan in total assets and 8.2 billion yuan in total liabilities, with a liability-to-asset ratio of 39.5%.